content

Filling and closing machine from Bosch honored with Red Dot Award

The filling and closing machine AFG 5000 from Bosch Packaging Technology recently received the internationally renowned “Red Dot Award” from the Design Zentrum Nordrhein-Westfalen...

Genstar Capital to Acquire CRF Health from Vitruvian Partners andCombine with Bracket

Genstar Capital, a leading investor in healthcare technology and services companies,is pleased to announce the acquisition of CRF Health, a global provider of eCOA...

Axol Bioscience Launch Human iPSC-derived Atrial Cardiomyocytes

Axol Bioscience, the human cell culture specialist, provide highly validated primary cells and iPSC-derived cells together with optimised media and growth supplements, launch their...

Sovereign announces the sale of Xendo to ProPharma Group – first exit from SCLP IV

Sovereign Capital Partners, the UK private equity Buy & Build specialist, is pleased to announce the realisation of its investment in Xendo - a...

Thermo Scientific Krios Cryo-TEM Instrument Installed at the Institut Pasteur

The Institut Pasteur officially unveiled its new Thermo Scientific Krios Cryo-TEM electron microscope at an event in Paris, France. The availability...

Servier and Galapagos announce start of global ROCCELLA Phase 2 clinical trial with S201086/GLPG1972 in osteoarthritis

Servier, an independent international pharmaceutical company, and the company Galapagos NV announce the start of a global Phase 2 trial with S201086/GLPG1972 in knee...

AbbVie Provides Update on Phase 3 Study of Ibrutinib in Blood Cancer Diffuse Large B-Cell Lymphoma and Ongoing Ibrutinib Clinical Program

AbbVie , a research-based global biopharmaceutical company, announced an update on a Phase 3 study (DBL3001) of ibrutinib (IMBRUVICA®) in untreated diffuse large B-cell...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read